Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 35589385)

  • 1. Nutrition-inflammation marker enhances prognostic value to ECOG performance status in overweight or obese patients with cancer.
    Zhang X; Zhang Q; Tang M; Zhang KP; Zhang XW; Song MM; Ruan GT; Sun Q; Li W; Xu HX; Cong MH; Deng L; Shi HP
    JPEN J Parenter Enteral Nutr; 2023 Jan; 47(1):109-119. PubMed ID: 35589385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of systemic inflammation and low performance status with reduced survival outcome in older adults with cancer.
    Ruan GT; Xie HL; Zhang HY; Zhang Q; Deng L; Wang ZW; Zhang X; Ge YZ; Hu CL; Tang M; Song MM; Zhang XW; Liu T; Li XR; Zhang KP; Yang M; Gong YZ; Chen YB; Yu KY; Cong MH; Pan L; Tang WZ; Wang KH; Shi HP
    Clin Nutr; 2022 Oct; 41(10):2284-2294. PubMed ID: 36096062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of systemic inflammation and for patients with colorectal cancer cachexia.
    Ruan GT; Xie HL; Yuan KT; Lin SQ; Zhang HY; Liu CA; Shi JY; Ge YZ; Song MM; Hu CL; Zhang XW; Liu XY; Yang M; Wang KH; Zheng X; Chen Y; Hu W; Cong MH; Zhu LC; Deng L; Shi HP
    J Cachexia Sarcopenia Muscle; 2023 Dec; 14(6):2813-2823. PubMed ID: 37902006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the prognostic value of MUST, ECOG-PS, mGPS and CT derived body composition analysis in patients with advanced lung cancer.
    Abbass T; Dolan RD; MacLeod N; Horgan PG; Laird BJ; McMillan DC
    Clin Nutr ESPEN; 2020 Dec; 40():349-356. PubMed ID: 33183562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of the modified advanced lung cancer inflammation index in overweight or obese patients with lung cancer: Results from a multicenter study.
    Xie H; Ruan G; Wei L; Zhang Q; Ge Y; Song M; Zhang X; Lin S; Liu X; Li X; Zhang K; Yang M; Tang M; Song C; Shi H
    JPEN J Parenter Enteral Nutr; 2023 Jan; 47(1):120-129. PubMed ID: 35975336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocyte to C-reactive protein ratio could better predict the prognosis of patients with stage IV cancer.
    Zhang HY; Xie HL; Ruan GT; Zhang Q; Ge YZ; Liu XY; Tang M; Song MM; Lin SQ; Yang M; Zhang XW; Xu HX; Song CH; Shi HP
    BMC Cancer; 2022 Oct; 22(1):1080. PubMed ID: 36266627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammation and Performance Status: The Cornerstones of Prognosis in Advanced Cancer.
    Rocha BMM; Dolan RD; Paiva CE; McGovern J; Paiva BSR; Preto DD; McMillan DC; Maia YCP; Laird BJ
    J Pain Symptom Manage; 2023 Apr; 65(4):348-357. PubMed ID: 36493981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An exploratory study examining the relationship between performance status and systemic inflammation frameworks and cytokine profiles in patients with advanced cancer.
    Dolan RD; Laird BJA; Klepstad P; Kaasa S; Horgan PG; Paulsen Ø; McMillan DC
    Medicine (Baltimore); 2019 Sep; 98(37):e17019. PubMed ID: 31517821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The G8 screening tool enhances prognostic value to ECOG performance status in elderly cancer patients: A retrospective, single institutional study.
    Takahashi M; Takahashi M; Komine K; Yamada H; Kasahara Y; Chikamatsu S; Okita A; Ito S; Ouchi K; Okada Y; Imai H; Saijo K; Shirota H; Takahashi S; Mori T; Shimodaira H; Ishioka C
    PLoS One; 2017; 12(6):e0179694. PubMed ID: 28640844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "How Long Have I Got?"-A Prospective Cohort Study Comparing Validated Prognostic Factors for Use in Patients with Advanced Cancer.
    Simmons C; McMillan DC; Tuck S; Graham C; McKeown A; Bennett M; O'Neill C; Wilcock A; Usborne C; Fearon KC; Fallon M; Laird BJ;
    Oncologist; 2019 Sep; 24(9):e960-e967. PubMed ID: 30975922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Significance of Preoperative Lymphocyte-to-C-Reactive Protein Ratio in Patients with Non-Metastatic Colorectal Cancer.
    Ou W; Zhou C; Zhu X; Lin L; Xu Q
    Onco Targets Ther; 2021; 14():337-346. PubMed ID: 33469310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FACT-Hep increases the accuracy of survival prediction in HCC patients when added to ECOG Performance Status.
    Gmür A; Kolly P; Knöpfli M; Dufour JF
    Liver Int; 2018 Aug; 38(8):1468-1474. PubMed ID: 29389088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship Between Prognostic Nutritional Index and Mortality in Overweight or Obese Patients with Cancer: A Multicenter Observational Study.
    Zhang X; Li JH; Zhang Q; Li QQ; Zhang KP; Tang M; Ge YZ; Li W; Xu HX; Guo ZQ; Shi HP
    J Inflamm Res; 2021; 14():3921-3932. PubMed ID: 34421305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Signatures Based on the Lymphocyte-to-C-Reactive Protein Ratio Predict the Prognosis of Patients with Early Breast Cancer: A Retrospective Study.
    Wang L; Zhang YL; Jiang C; Duan FF; Yuan ZY; Huang JJ; Bi XW
    J Inflamm Res; 2022; 15():3957-3974. PubMed ID: 35860229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic impact of the lymphocyte-to-C-reactive protein ratio in patients with unresectable or recurrent advanced gastric cancer treated with first- and second-line treatment.
    Matsunaga T; Saito H; Fukumoto Y; Kuroda H; Taniguchi K; Takahashi S; Osaki T; Iwamoto A; Fukuda K; Shimizu S; Shishido Y; Miyatani K; Fujiwara Y
    Surg Today; 2023 Aug; 53(8):940-948. PubMed ID: 36595075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis of comorbidity and performance indices for prediction of oncological outcomes in patients with upper tract urothelial carcinoma who were treated with radical nephroureterectomy.
    Aziz A; Fritsche HM; Gakis G; Kluth LA; Hassan Fa; Engel O; Dahlem R; Otto W; Gierth M; Denzinger S; Schwentner C; Stenzl A; Shariat SF; Fisch M; Burger M; Rink M
    Urol Oncol; 2014 Nov; 32(8):1141-50. PubMed ID: 24856977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic effect of sixteen malnutrition/inflammation-based indicators on the overall survival of chemotherapy patients.
    Liu T; Liu C; Deng L; Song M; Lin S; Shi H
    Front Immunol; 2023; 14():1117232. PubMed ID: 36875131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical utility of the pretreatment glasgow prognostic score in patients with advanced inoperable non-small cell lung cancer.
    Leung EY; Scott HR; McMillan DC
    J Thorac Oncol; 2012 Apr; 7(4):655-62. PubMed ID: 22425914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphocyte-to-C-reactive protein ratio and score are clinically feasible nutrition-inflammation markers of outcome in patients with gastric cancer.
    Okugawa Y; Toiyama Y; Yamamoto A; Shigemori T; Ichikawa T; Yin C; Suzuki A; Fujikawa H; Yasuda H; Hiro J; Yoshiyama S; Ohi M; Araki T; McMillan DC; Kusunoki M
    Clin Nutr; 2020 Apr; 39(4):1209-1217. PubMed ID: 31155370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive prognostic effects of systemic inflammation and Insulin resistance in women with breast cancer with different BMI: a prospective multicenter cohort.
    Ruan GT; Xie HL; Hu CL; Liu CA; Zhang HY; Zhang Q; Wang ZW; Zhang X; Ge YZ; Lin SQ; Tang M; Song MM; Zhang XW; Liu XY; Zhang KP; Yang M; Yu KY; Wang KH; Hu W; Deng L; Cong MH; Shi HP
    Sci Rep; 2023 Mar; 13(1):4303. PubMed ID: 36922570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.